PT1024822E - Cd8 como inibidor do sistema imunitario celular - Google Patents

Cd8 como inibidor do sistema imunitario celular

Info

Publication number
PT1024822E
PT1024822E PT98950218T PT98950218T PT1024822E PT 1024822 E PT1024822 E PT 1024822E PT 98950218 T PT98950218 T PT 98950218T PT 98950218 T PT98950218 T PT 98950218T PT 1024822 E PT1024822 E PT 1024822E
Authority
PT
Portugal
Prior art keywords
inhibitor
cellular immunity
immunity system
ctl
activity
Prior art date
Application number
PT98950218T
Other languages
English (en)
Inventor
Bent Karsten John Jakobsen
George Fu Gao
Ulrich Conrad Gerth
Andrew Kelvin Sewell
Original Assignee
Avidex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidex Ltd filed Critical Avidex Ltd
Publication of PT1024822E publication Critical patent/PT1024822E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70517—CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT98950218T 1997-10-28 1998-10-28 Cd8 como inibidor do sistema imunitario celular PT1024822E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722779.7A GB9722779D0 (en) 1997-10-28 1997-10-28 Human CD8 as an inhibitor of the cellular immune system

Publications (1)

Publication Number Publication Date
PT1024822E true PT1024822E (pt) 2002-09-30

Family

ID=10821228

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98950218T PT1024822E (pt) 1997-10-28 1998-10-28 Cd8 como inibidor do sistema imunitario celular

Country Status (17)

Country Link
US (1) US20070191278A1 (pt)
EP (1) EP1024822B1 (pt)
JP (1) JP2001521005A (pt)
KR (1) KR100585246B1 (pt)
CN (1) CN1256147C (pt)
AT (1) ATE215833T1 (pt)
AU (1) AU752910B2 (pt)
CA (1) CA2308463A1 (pt)
DE (1) DE69804839T2 (pt)
DK (1) DK1024822T3 (pt)
ES (1) ES2175798T3 (pt)
GB (1) GB9722779D0 (pt)
HK (1) HK1031099A1 (pt)
NO (1) NO20002148L (pt)
NZ (1) NZ504240A (pt)
PT (1) PT1024822E (pt)
WO (1) WO1999021576A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929993D0 (en) * 1999-12-17 2000-02-09 Avidex Ltd Substances
GB0107628D0 (en) * 2001-03-27 2001-05-16 Avidex Ltd Substances
GB0114533D0 (en) 2001-06-14 2001-08-08 Avidex Ltd Substances
GB0115071D0 (en) * 2001-06-20 2001-08-15 Avidex Ltd Substances
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
GB2398300A (en) * 2003-02-17 2004-08-18 Isis Innovation Method and compositions for boosting immune response
US20090053249A1 (en) * 2004-07-20 2009-02-26 Yan Qi Specific Inhibition of Autoimmunity and Diseases Associated With Autoantigens
GB0510627D0 (en) 2005-05-25 2005-06-29 Avidex Ltd Polypeptides
US8871515B2 (en) 2008-09-17 2014-10-28 Isogenis, Inc. Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
BR122021026173B1 (pt) * 2010-12-09 2023-12-05 The Trustees Of The University Of Pennsylvania Composição farmacêutica
WO2016149404A1 (en) 2015-03-16 2016-09-22 California Institute Of Technology Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
WO2017176769A1 (en) * 2016-04-04 2017-10-12 Indi Molecular, Inc. Cd8-specific capture agents, compositions, and methods of using and making
EP3519425B1 (en) 2016-09-29 2024-02-28 Indi Molecular, Inc. Compositions for detection, inhibition and imaging of indoleamine 2,3-dioxygenase 1 (ido1) and methods of making and using same
EP3638687A1 (en) 2017-06-15 2020-04-22 Indi Molecular, Inc. Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242687A (en) * 1989-03-15 1993-09-07 Tkb Associates Limited Partnership Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
US5601828A (en) * 1989-03-15 1997-02-11 Tkb Associates Limited Partnership CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment
WO1990010385A1 (en) * 1989-03-15 1990-09-20 Tykocinski Mark L Cd8-based pharmaceuticals
US5645837A (en) * 1995-01-17 1997-07-08 Thomas Jefferson University Peptides that inhibit T cell activation and methods of using the same

Also Published As

Publication number Publication date
AU752910B2 (en) 2002-10-03
DE69804839D1 (de) 2002-05-16
EP1024822B1 (en) 2002-04-10
ATE215833T1 (de) 2002-04-15
JP2001521005A (ja) 2001-11-06
NO20002148D0 (no) 2000-04-27
GB9722779D0 (en) 1997-12-24
KR20010024570A (ko) 2001-03-26
CA2308463A1 (en) 1999-05-06
EP1024822A1 (en) 2000-08-09
WO1999021576A1 (en) 1999-05-06
DE69804839T2 (de) 2002-10-10
NO20002148L (no) 2000-06-27
CN1256147C (zh) 2006-05-17
KR100585246B1 (ko) 2006-06-01
NZ504240A (en) 2002-11-26
CN1283120A (zh) 2001-02-07
ES2175798T3 (es) 2002-11-16
DK1024822T3 (da) 2002-08-05
HK1031099A1 (en) 2001-06-01
AU9637498A (en) 1999-05-17
US20070191278A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
PT1024822E (pt) Cd8 como inibidor do sistema imunitario celular
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
FI961621A0 (fi) Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit
AU5624699A (en) Use of 5ht-6 antagonists
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
MXPA05001298A (es) Compuestos con el sistema biciclo[4.2.1] nonano para el tratamiento de infecciones por flaviviridae.
BR0015501A (pt) Compostos de aminoalquil glucosaminida fosfato e uso dos mesmos como adjuvantes e agentes de efeito imune
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
MX9205046A (es) 1h-imidazo-(4,5-c)quinolin-4-aminas 1-substituidas
AR024138A1 (es) Inhibidores de la proliferacion celular
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
IS2216B (is) Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
EP1007553A4 (en) TOXIN RECEPTORS FROM ZONULA OCCLUDENS
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
PT977716E (pt) Utilizacao de alcoois como aditivos para rebocos e/ou argamassas
PT880520E (pt) Derivados da benzo¬c|quinolizina sua preparacao e uso como inibidores da 5-alfa-reductase
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
MXPA02002007A (es) Compuestos de bencimidazol sustituidos con alcoxi, preparaciones farmaceuticas que contienen los mismos, metodos para usarlos.
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof
PE92098A1 (es) N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
DE59609482D1 (de) Anellierte beta-carboline
HUP9904002A2 (hu) Hasnyálmirigy-gyulladás kezelésére vagy megelőzésére alkalmas, hatóanyagként diarilalkánszármazékokat tartalmazó gyógyászati készítmények
DE69812945D1 (de) Tricyclische aminooxyamide derivate als farnesyl protein transferase inhibitoren